Join Peter Diamandis, Tony Robbins, and the COVAXX scientific advisory board for an exclusive conversation about the science behind COVAXX’s COVID-19 vaccine development.
George Siber, MD - Chief Scientific Officer, ClearPath Vaccines
Thomas P. Monath, MD - Chief Scientific Officer, Crozet BioPharma
Wayne Koff, Ph.D - CEO, Human Vaccines Project
As we hit over 17 million people infected, and more than 668,000 COVID-related deaths across the globe, nothing will return us to normalcy until a safe and effective vaccine is in place!
The company is called COVAXX-- a spinout of United Biomedical, a 30+ year-old vaccine company that has a prov...
Salim Ismail (head of Exponential Organizations and OpenExO) and Peter discuss being an Exponential Entrepreneur during COVID-19.
How do you pivot your company? How do you digitize and use exponential technology to transform your company into an exponential one during this crisis? It's more impo...
Peter joins John Sculley for a discussion on exciting new startups that will change the digital economy. This is a great peek into the future of the digital economy in the next decade and beyond!